dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Vergara Arana, Ander |
dc.contributor.author | Jacobs Cachá, Concepció |
dc.contributor.author | Llorens Cebriá, Carmen |
dc.contributor.author | Ortiz, Alberto |
dc.contributor.author | Martinez Diaz, Irene |
dc.contributor.author | Martos Guillamé, Nerea |
dc.contributor.author | Dominguez Baez, Pamela |
dc.contributor.author | Molina Van den Bosch, Mireia |
dc.contributor.author | Bermejo Garcia, Sheila |
dc.contributor.author | Pieper, Michael Paul |
dc.contributor.author | Benito Villabriga, Begoña |
dc.contributor.author | Soler Romeo, Maria Jose |
dc.date.accessioned | 2022-11-30T13:16:42Z |
dc.date.available | 2022-11-30T13:16:42Z |
dc.date.issued | 2022-10-24 |
dc.identifier.citation | Vergara A, Jacobs-Cacha C, Llorens-Cebria C, Ortiz A, Martinez-Diaz I, Martos N, et al. Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice. 2022 Oct 24;23(21):12823. |
dc.identifier.issn | 1422-0067 |
dc.identifier.uri | https://hdl.handle.net/11351/8563 |
dc.description | Malaltia renal crònica; Nefropatia diabètica; Antagonistes dels receptors d'endotelina |
dc.description.sponsorship | The following study was funded with Spanish government grants (FONDO DE INVESTIGACIÓN SANITARIA-FEDER, ISCIII (PI17/00257 and RICORS RD21/0005/0016)) and with financial support from Boehringer Ingelheim Pharma GmbH. The funders had no role in study design, analyses, interpretation of the data, drafting of the manuscript, or decision to submit the manuscript for publication. The funders were allowed to comment on the manuscript prior to publication; however, the final wording was at the full discretion of the investigators. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | International Journal of Molecular Sciences;23(21) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Diabetis no-insulinodependent - Tractament |
dc.subject | Ratolins |
dc.subject | Cor - Malalties - Complicacions |
dc.subject | Ronyons - Malalties |
dc.subject.mesh | Diabetes Mellitus, Type 2 |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Drug Therapy, Combination |
dc.subject.mesh | Mice |
dc.subject.mesh | Cardio-Renal Syndrome |
dc.title | Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/ijms232112823 |
dc.subject.decs | diabetes mellitus tipo II |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | farmacoterapia combinada |
dc.subject.decs | ratones |
dc.subject.decs | síndrome cardiorrenal |
dc.relation.publishversion | https://doi.org/10.3390/ijms232112823 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Vergara A, Bermejo S, Soler MJ] Grup de Recerca en Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Jacobs-Cacha C, Llorens-Cebria C, Martinez-Diaz I, Martos N, Dominguez-Báez P, Van den Bosch MM] Grup de Recerca en Nefrologia i Trasplantament Renal, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Ortiz A] IIS-Fundación Jiménez Diaz, Fundación Renal Iñigo Álvarez de Toledo-IRSIN, REDinREN, Instituto de Investigación Carlos III, Universidad Autónoma de Madrid, Madrid, Spain. [Pieper MP] Cardio-Metabolic Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riß, Germany. [Benito B] Grup de Recerca en Malalties Cardiovasculars, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 36361612 |
dc.identifier.wos | 000881250900001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2017-2020/RD21%2F0005%2F0016 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |